Seroconversion in COVID-19 Recovered Population
NCT04558385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 275
Last updated 2021-04-01
Summary
This study investigate the kinetics of IgG responses to both N and S proteins in the subjects who suffered from COVID 19 and then had recovered.
Conditions
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
IgG SARS CoV2
IgG SARS CoV 2 will be checked in serum of COVID 19 recovered population
Sponsors & Collaborators
-
Lahore General Hospital
lead OTHER_GOV
Principal Investigators
-
Amina Asif, MPhilMicro · LahoreGeneralHospital.Lahore
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2021-03-31
- Completion
- 2021-03-31
Countries
- Pakistan
Study Locations
More Related Trials
-
A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.
NCT06862531 ·Status: COMPLETED ·Phase: NA
-
Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive
NCT04605952 ·Status: COMPLETED
-
Neutralizing Antibody Level After COVID-19 Vaccination
NCT05083026 ·Status: RECRUITING
-
Seroprevalence of MERS-CoV IgG in Healthcare Workers
NCT02497885 ·Status: COMPLETED
-
Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants
NCT05858502 ·Status: RECRUITING ·Phase: NA
-
Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms
NCT05484700 ·Status: UNKNOWN
-
COVID-19 IgG Formation in Physicians at ALGH and Their Household Members
NCT04540484 ·Status: COMPLETED
-
COVID-19 Antibody and Reinfection Study
NCT05365750 ·Status: COMPLETED
-
Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2
NCT04655521 ·Status: COMPLETED
-
COVID-19 IgG Antibodies in the Serum of Recovered Patients
NCT04470414 ·Status: UNKNOWN
-
COVID-19 Antibodies Among Healthcare Workers
NCT04425889 ·Status: COMPLETED
-
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
NCT04453280 ·Status: COMPLETED
-
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination
NCT04880174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts
NCT04808986 ·Status: COMPLETED ·Phase: NA
-
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
NCT04469634 ·Status: COMPLETED ·Phase: NA
-
Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta
NCT04945811 ·Status: COMPLETED ·Phase: NA
-
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
NCT04383587 ·Status: COMPLETED ·Phase: NA
-
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre
NCT04446338 ·Status: UNKNOWN
-
COVID-19 Immune Repertoire Sequencing
NCT04368143 ·Status: COMPLETED
-
Investigating Development of Autoimmunity in Post-Acute COVID-19 Syndrome (PACS)
NCT05459506 ·Status: UNKNOWN
-
Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19
NCT04469153 ·Status: UNKNOWN
-
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
NCT04389294 ·Status: COMPLETED ·Phase: NA
-
Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients
NCT04817553 ·Status: COMPLETED
-
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
NCT04483908 ·Status: COMPLETED
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN